Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies.

Ullrich Congenital Muscular Dystrophy (UCMD), Bethlem Myopathy (BM) and Congenital Myosclerosis are diseases due to mutations in the genes encoding the extracellular matrix protein collagen VI. A dystrophic mouse model where collagen VI synthesis was prevented by targeted inactivation of the Col6a1 gene allowed the investigation of pathogenesis, which revealed the existence of a Ca2+-mediated dysfunction of mitochondria and sarcoplasmic reticulum, and of defective autophagy. Key events are dysregulation of the mitochondrial permeability transition pore, an inner membrane high-conductance channel that for prolonged open times causes mitochondrial dysfunction; and inadequate removal of defective mitochondria, which amplifies the damage. Consistently, the Col6a1-/- myopathic mice could be cured with through inhibition of cyclophilin D, a matrix protein that sensitizes the pore to opening, and through stimulation of autophagy. Similar defects contribute to disease pathogenesis in patients irrespective of the genetic lesion causing the collagen VI defect. These studies indicate that PTP opening and defective autophagy represent key elements for skeletal muscle fiber death, and provide a rationale for the use of cyclosporin A and its non immunosuppressive derivatives in patients affected by collagen VI myopathies, a strategy that holds great promise for treatment.